Plasma sLOX-1 levels correlated significantly with several cardiovascular risk factors and when adjusting for the factors included in the Framingham risk score, as well as for diabetes, the association between sLOX-1 and risk of myocardial infarction became weaker. Here, OLR1 is linked to myocardial infarction.